Klaus Schafer - 29 Sep 2022 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Kent Tapper, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
29 Sep 2022
Net transactions value
$0
Form type
4
Filing time
30 Sep 2022, 21:21:11 UTC
Previous filing
22 Jun 2022
Next filing
29 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Stock Options (option to buy) Award $0 +23,500 $0.000000 23,500 29 Sep 2022 Common Stock, par value $0.0001 23,500 $12.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 29, 2022, subject to the reporting person's continued service through the applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney